Tel : 0086-021-5165-9050 / 0086-15618223367 Email : sales@atkchmemical.com
NS 161
ATK-04870
98.00%
153587-01-0
C15H8F6N2O2
362.2266
Article number Size Operate
ATK-04870 10MG 10MG Inquiry
ATK-04870 25MG 25MG Inquiry
Detection information
Purity: 99.99%
Product Details
CAS Number 153587-01-0 Appearance
Catalog NO ATK-04870 MDL Number
Molecular Formula C15H8F6N2O2 Molecular Weight 362.2266
Boiling Point Melting Point
Flash Poin Density 1.563±0.06 g/cm3 (20 ºC 760 Torr),
Synonyms 1-(2-Hydroxy-5-(trifluoromethyl)phenyl)-5-(trifluoromethyl)-1H-benzo[d]imidazol-2(3H)-one;2H-Benzimidazol-2-one,1,3-dihydro-1-[2-hydroxy-5-(trifluoromethyl)phenyl]-5-(trifluoromethyl)-;3-[2-hydroxy-5-(trifluoromethyl)phenyl]-6-(trifluoromethyl)-1H-benzimidazol-2-one;NS 1619;NS-1619;1,3-Dihydro-1-[2-hydroxy-5-(trifluoromethyl)phenyl]-5-(trifluoromethyl)-2H-benzimidazol-2-one;Lopac-N-170;NS 1619 (1,3-DIHYDRO-1-(2-HYDROXY-5-(TRI FLUOROMETHYL)PHEN;1-(2-hydroxy-5-(trifluoroMethyl)phenyl)-5-(trifluoroMethyl)-1H-b;NS1619;1-(2'-Hydroxy-5'-trifluoromethylphenyl)-5-trifluoromethyl-2(3H)-benzimidazolone;1-[2-hydroxy-5-(trifluoromethyl)phenyl]-5-(trifluoromethyl)-1,3-dihydro-2h-benzimidazol-2-one;3-[2-hydroxy-5-(trifluoromethyl)phenyl]-6-(trifluoromethyl)-;1-(2-hydroxy-5-(trifluoromethyl)phenyl)-5-(trifluoromethyl)-1H-benzo[d]imidazol-2(3H)-one;1,3-DIHYDRO-1-[2-HYDROXY-5-(TRIFLUOROMETHYL)PHENYL]-5-(TRIFLUOROMETHYL)-2H-BENZIMIDAZOL-2-ONE;1,3-dihydro-1-(2-hydroxy-5-(trifluoromethyl)phenyl)-5-(trifluoromethyl)-2H-Benzimidazol-2-one;Lopac0_000892;MFCD00928190;NCGC00015720-03;KBio2_005281;KBio3_000290;KBio3_000289;EU-0100892;KBioGR_000145;Tox21_500892;BSPBio_001425;SMR001254108;BDBM50347497;5-trifluoromethyl-2,3-dihydro-1-(5-trifluoromethyl-2-hydroxyphenyl)-1H-2-oxo-benzimidazole;NCGC00094210-02;1-(2-Hydroxy-5-(trifluoromethyl)phenyl)-5-(trifluoromethyl)-1H-benzo[d]imid azol-2(3H)-one;BCP23926;AC-35355;HMS3402H07;KBioSS_000145;AKOS016007330;MLS002172485;HMS2233C07;HMS1791H07;SDCCGSBI-0050867.P002;1-[2-hydroxy-5-(trifluoromethyl)phenyl]-5-(trifluoromethyl)-2,3-dihydro-1H-1,3-benzodiazol-2-one;1,3-Dihydro-1-[2-hydroxy-5-(trifluo romethyl)phenyl]-5-(trifluoromethyl)-2H-benzimidazol-2-one;BCBcMAP01_000241;Bio2_000145;NCGC00015720-04;NCGC00015720-07;NCGC00094210-03;GTPL4272;CHEMBL384903;IDI1_033895;NS 1619, powder;KBio2_002713;KC-127;NCGC00015720-05;SCHEMBL2820871;153587-01-0;AMY36458;NCGC00015720-02;Bio2_000625;NCGC00015720-06;2H-Benzimidazol-2-one, 1,3-dihydro-1-(2-hydroxy-5-(trifluoromethyl)phenyl)-5-(trifluoromethyl)-;Q27088047;HMS3374I04;HMS1361H07;DTXSID80165363;KBio2_000145;1-(2-Hydroxy-5-trifluoromethylphenyl)-5-trifluoromethyl-1,3-dihydro-2H-benzimidazol-2-one;CS-3613;SR-01000075337;NCGC00261577-01;NCGC00015720-11;HB1048;N-170;A809445;N1191;FT-0643507;HY-12496;NCGC00015720-01;NCGC00094210-01;SR-01000075337-1;J-009032;AS-55902;EX-A3548;BRD-K54210043-001-02-0;NCGC00094210-04;HMS1989H07;C15H8F6N2O2;LP00892;1-(2-hydroxy-5-(trifluoromethyl)phenyl)-5-(trifluoromethyl)-1,3-dihydro-2H-benzo[d]imidazol-2-one;CCG-204974;CHEBI:34879;HMS3262D06
Storage Condition
Safety
GHS Pictogram
Signal Word UN Number
Hazard Statements Class
Precautionary Statements Packing Group
Description
There is currently no product overview available!